DLEC1

gene product
CFAP81, DLC1
The cytogenetic location of this gene is 3p21.3, and it is located in a region that is commonly deleted in a variety of malignancies. Down-regulation of this gene has been observed in several human cancers including lung, esophageal, renal tumors, and head and neck squamous cell carcinoma. In some cases, reduced expression of this gene in tumor cells is a result of aberrant promoter methylation. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins. [provided by RefSeq, Mar 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
176 antibodies from 22 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
NovoPro Bioscience Inc.
1 antibody
GeneTex
1 antibody
Invitrogen Antibodies
3 antibodies
antibodies-online
75 antibodies
LifeSpan BioSciences, Inc.
33 antibodies
Aviva Systems Biology
3 antibodies
Affinity Biosciences
1 antibody
Abnova Corporation
2 antibodies
Atlas Antibodies
1 antibody
Boster Biological Technology
1 antibody
Biorbyt
9 antibodies
Abgent
2 antibodies
MyBioSource
2 antibodies
ProSci
3 antibodies
Abbexa
4 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
St John's Laboratory
1 antibody
Sigma-Aldrich
2 antibodies
Creative Diagnostics
3 antibodies
United States Biological
26 antibodies
Leading Biology
1 antibody